Law Articles

Return to Law Dictionary Index

How to File a claim for Celebrex injury

by Jefferson Highway, General Counsel

There is mounting evidence to suggest that Celebrex (aka celecoxib) is linked to an increased risk of blood clots, heart attacks and strokes. Celebrex is one of the newer anti arthritic drugs called COX-2 inhibitors that were launched in the 1990s, and is marketed by Pharmacia Corporation and Pfizer Inc. The drug is prescribed for osteoarthritis, adult rheumatoid arthritis, and menstrual cramps. The FDA is currently taking independent advice on whether these COX-2 inhibitors, and Celebrex in particular, are safe to remain on sale. Current studies "strongly suggest" the COX-2 inhibitors increase the risk of cardiovascular problems, says Dr. Ned Braunstein, senior director of Merck Research Laboratories.

A related study from the Cleveland Clinic, published in the Journal of the American Medical Association suggested that the risk of cardiovascular problems (including but not limited to heart attacks, chest pains, stroke, death and blood clots), was over twice as high in the rofecoxib sample than in the control group - a significant find given that the analysis was based on more than 8,000 patients.

In yet another study of over 42,000 participants, 0.52% of patients taking a placebo pill had a heart attack each year compared to 0.74% for patients taking rofecoxib and 0.80% for those taking celecoxib. It's big business too - the drug will do over $6 billion this year alone.

Return to Health Law

Return to Law Dictionary Index